Proxy Voting
By now shareholders should have received a proxy statement and voting card for NRx’s special meeting to be held on March 21, 2024. All votes need to be completed by March 20, 2024.
If you have a control number, you can vote here: cstproxyvote.com.
If you have not yet received any voting instructions, the Company can help. If you have any issues with voting, please reach out to Stephen Freyman of Alliance Advisors for immediate assistance. Stephen’s contact info is freyman@allianceadvisors.com T: 1 (973) 518-3365.
Mission
NRx brings hope:
Life-saving medicines
For people living with unmet medical needs.
We believe in a world where scientific advancement makes untreatable diseases treatable.
NRx Team
Chief Executive Officer & Director
Chairman and Chief Scientist
Chief Financial Officer
Chief Technology Officer
Chief Business Officer
Medical Director
Regulatory Affairs Officer
Board of Directors
Audit Committee Chair
Chairman and Chief Scientist
Chief Executive Officer & Director
Corporate Governance
Advisors
Co-founder & Chair, Scientific Advisory Board
Chief Methodologist
Principal Investigator (EU)
Chief Strategy Officer & Senior Scientist
Clinical Advisor
Principal Investigator
Clinical Advisor
Regulatory & Patient Advocacy Advisor